Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differentiation therapy.

Alexander I Spira1, Michael A Carducci

  • 1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB Room 1M89, Baltimore, MD 21231, USA. spiraal@jhmi.edu

Current Opinion in Pharmacology
|August 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical applications of PARP inhibitors in breast, ovarian, and prostate cancer: current insights and future directions.

Clinical advances in hematology & oncology : H&O·2026
Same author

BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations.

Molecular cancer therapeutics·2026
Same author

Disrupted molecular glue complex drives RAS inhibitor resistance.

Cell·2026
Same author

Phase 2 study of cabozantinib (XL184) with nivolumab and ipilimumab for the treatment of poorly differentiated neuroendocrine carcinomas (ETCTN10315).

The oncologist·2026
Same author

SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in <i>KRAS</i> G12C NSCLC.

Future oncology (London, England)·2026
Same author

Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer.

The New England journal of medicine·2026

Differentiation therapy aims to revert cancer cells to a benign state. This emerging oncology field shows promise with several agents in clinical use or development.

Area of Science:

  • Oncology
  • Cellular Biology

Background:

  • Differentiation therapy is an emerging field in oncology.
  • It aims to biologically switch off cancer cells, reverting them to a benign phenotype.

Purpose of the Study:

  • To explore the foundational concepts of differentiation therapy.
  • To review agents studied for their potential in cancer treatment.

Main Methods:

  • Review of existing scientific literature on differentiation therapy.
  • Analysis of agents investigated for their efficacy.

Main Results:

  • The concept of differentiation therapy is theoretically sound.
  • Multiple agents have been investigated, with some showing clinical promise.

Related Experiment Videos

Conclusions:

  • Differentiation therapy represents a novel approach in cancer treatment.
  • Ongoing research and clinical studies indicate a promising future for this therapeutic strategy.